Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Should You Sell?

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY) gapped down before the market opened on Tuesday . The stock had previously closed at $9.93, but opened at $9.33. Sysmex shares last traded at $9.64, with a volume of 2,979 shares changing hands.

Sysmex Stock Down 4.7%

The stock has a market capitalization of $5.72 billion, a price-to-earnings ratio of 18.94 and a beta of 1.14. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.33 and a quick ratio of 2.44. The business has a fifty day moving average of $9.46 and a 200 day moving average of $10.60.

Sysmex (OTCMKTS:SSMXY) last posted its earnings results on Thursday, February 12th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.01. Sysmex had a return on equity of 9.27% and a net margin of 8.86%.The company had revenue of $837.32 million during the quarter, compared to analysts’ expectations of $819.99 million. As a group, equities analysts predict that Sysmex Corporation ADR will post 0.57 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.